You have 9 free searches left this month | for more free features.

City

Sherbrooke (1)

Condition

GnRH Antagonist (1)

Menorrhagia (1)

Polycystic Ovarian Syndrome (1)

Preimplantation Genetic Testing (1)

Progestin-primed Ovarian Stimulation (1)

Renal Transplantation (1)

Overall Status

Not yet recruiting (2)

Terminated (1)

Sign in for free

Phase

phase 3 (2)

phase 2 (1)

Sponsor

Guy Waddell (1)

ITB-Med LLC (1)

ShangHai Ji Ai Genetics & IVF Institute (1)

Collaborator

CSSS Chicoutimi (1)

Intervention

mpa (3)

atg (1)

belatacept (1)

corticosteroids (1)

gnrh antagonist (1)

placebo (1)

tac (1)

tcd601 (1)

Study Documents

Intervention Type

drug (3)

biological (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

mpa

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Renal Transplantation Trial (TCD601, belatacept, ATG)

Not yet recruiting

Renal Transplantation

TCD601
+5 more

(no location specified)

Dec 20, 2022

Menorrhagia Trial in Sherbrooke (MPA, )

Terminated

Menorrhagia

MPA
placebo

Sherbrooke, Quebec, Canada

Centre Hospitalier Universitaire de Sherbrooke

May 16, 2022

Preimplantation Genetic Testing, Progestin-primed Ovarian Stimulation, Polycystic Ovarian Syndrome Trial (GnRH antagonist, MPA)

Not yet recruiting

Preimplantation Genetic Testing
+3 more

GnRH antagonist
MPA

(no location specified)

Apr 9, 2022